Utah Retirement Systems’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.32M | Hold |
64,262
| – | – | 0.02% | 519 |
|
2025
Q1 | $2M | Sell |
64,262
-338
| -0.5% | -$10.5K | 0.02% | 548 |
|
2024
Q4 | $1.65M | Hold |
64,600
| – | – | 0.02% | 605 |
|
2024
Q3 | $1.83M | Hold |
64,600
| – | – | 0.02% | 586 |
|
2024
Q2 | $1.7M | Buy |
64,600
+500
| +0.8% | +$13.2K | 0.02% | 584 |
|
2024
Q1 | $1.95M | Sell |
64,100
-100
| -0.2% | -$3.04K | 0.02% | 571 |
|
2023
Q4 | $1.8M | Buy |
64,200
+400
| +0.6% | +$11.2K | 0.02% | 575 |
|
2023
Q3 | $1.73M | Buy |
63,800
+200
| +0.3% | +$5.43K | 0.02% | 561 |
|
2023
Q2 | $1.96M | Sell |
63,600
-2,700
| -4% | -$83K | 0.03% | 535 |
|
2023
Q1 | $2.39M | Hold |
66,300
| – | – | 0.03% | 474 |
|
2022
Q4 | $2.62M | Buy |
66,300
+600
| +0.9% | +$23.7K | 0.04% | 411 |
|
2022
Q3 | $2.64M | Buy |
65,700
+200
| +0.3% | +$8.03K | 0.04% | 395 |
|
2022
Q2 | $2.75M | Buy |
65,500
+7,500
| +13% | +$315K | 0.04% | 398 |
|
2022
Q1 | $2.26M | Sell |
58,000
-1,000
| -2% | -$38.9K | 0.03% | 509 |
|
2021
Q4 | $2.35M | Buy |
59,000
+200
| +0.3% | +$7.97K | 0.03% | 520 |
|
2021
Q3 | $2.13M | Sell |
58,800
-2,800
| -5% | -$101K | 0.03% | 543 |
|
2021
Q2 | $2.53M | Buy |
61,600
+200
| +0.3% | +$8.2K | 0.03% | 509 |
|
2021
Q1 | $2.68M | Buy |
61,400
+40,300
| +191% | +$1.76M | 0.04% | 467 |
|
2020
Q4 | $1.06M | Buy |
+21,100
| New | +$1.06M | 0.02% | 730 |
|